LTBK-04 FIRST RESULTS OF THE RANDOMIZED PHASE II STUDY ON DEPATUX –M ALONE, DEPATUX-M IN COMBINATION WITH TEMOZOLOMIDE AND EITHER TEMOZOLOMIDE OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA: FIRST REPORT FROM INTELLANCE 2/EORTC TRIAL 1410

Autor:	Michael Weller, Ho-Jin Lee, Sarah Nuyens, Jim Looman, Jan-Peter de Geus, Martin J. van den Bent, Vassilis Golfinopoulos, Paul Clement, Annemiek M E Walenkamp, Marica Eoli, Joana Brilhante, Paul Sanghera, Juan Manuel Sepúlveda, Pim J. French, Marion Smits, Filip de Vos, Maarten Spruyt, Nicolas Whenham, Hendrikus J. Dubbink, Thierry Gorlia, Jean-Sebastien Frenel, Olivier Chinot, Johan M. Kros, Alba A. Brandes
Jazyk:	angličtina
Rok vydání:	2017
Předmět:	Oncology Cancer Research medicine.medical_specialty Temozolomide business.industry medicine.medical_treatment Phases of clinical research Lomustine medicine.disease Radiation therapy 03 medical and health sciences Abstracts 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine Neurology (clinical) business 030217 neurology & neurosurgery medicine.drug Glioblastoma
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1845ad7cc5eae5f51ed0297c4884f18c https://europepmc.org/articles/PMC5695624/ Zobrazit plný text záznamu